Although 20–70% of sporadic ovarian tumors display loss of heterozygosity (LOH) in the BRCA1/2 loci, indicating essential role of these genes in ovarian cancer pathogenesis, somatic mutations of these genes are relatively rare finding 8, 9, 10. The gene discussed is BRCA1; the disease is ovarian cancer.